Showing results (381-390 of 403) with videos related to

Sort By:
Pageof 41
Frontiers in Microbiology|December 10, 2016
High Diversity of Genogroup I Picobirnaviruses in MammalsPatrick C Y Woo, Jade L L Teng, Ru Bai, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesiaShavonne L Teng, Rocco Latorre, Divya Bhansali, et al.
Frontiers in Microbiology|February 26, 2021
High Prevalence and Mechanism Associated With Extended Spectrum Beta-Lactamase-Positive Phenotype in Laribacter hongkongensisJade L L Teng, Ruibang Luo, Bone S F Tang, et al.
The Lancet. Oncology|April 12, 2021
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyRobert L Coleman, Domenica Lorusso, Christine Gennigens, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 7, 2023
[Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase: a multicenter retrospective study]Z Y Shen, X C Chen, H R Shan, et al.
Plos Genetics|March 14, 2009
The complete genome and proteome of Laribacter hongkongensis reveal potential mechanisms for adaptations to different temperatures and habitatsPatrick C Y Woo, Susanna K P Lau, Herman Tse, et al.
The Journal of Clinical Investigation|August 29, 2018
Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for EnterovirusMan Lung Yeung, Lilong Jia, Cyril C Y Yip, et al.
Blood Advances|January 4, 2018
Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCTKate H Gartlan, Antiopi Varelias, Motoko Koyama, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Nature Immunology|August 1, 2017
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsYulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Pageof 41